Supplementary Figure 4
Supplementary Figure 4 Comparative cellular uptake and intracellular stability of EZH2 peptides. MLL-AF9 cells were treated with the indicated FITC-derivatized EZH2 petides (5 μM) and lysates prepared at 1, 2, 4, and 8 hours, followed by electrophoresis and uorescence scan. We used unmodi ed FITC-EZH2 peptide as a negative control and the same sequence fused to the cell penetrating sequence TAT as a positive control V e h i c l e Fig. 1, 2a, 2b , and 2c
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